23
Participants
Start Date
October 31, 2009
Primary Completion Date
January 31, 2011
Study Completion Date
January 31, 2011
INFUSE® Bone Graft
Patients will be treated with the commercially available INFUSE® Bone Graft material applied to an ACS in the area of the dental implant on Day 0 (Surgery). A follow-up visit will take place 2 weeks after implant of the INFUSE® Bone Graft material, or as regularly scheduled as the standard of care (SOC) for the facility. Patients will return to the facility for final End of Study (EOS) assessments 6 months after surgery for placement of the appropriate prosthetic, and assessment of osseointegration and stability. Between the follow-up visit and the EOS visit, patients will be seen as per the SOC schedule for the facility.
Philadelphia
Denver
Dallas
Houston
Fullerton
Collaborators (1)
Averion International Corporation
INDUSTRY
Medtronic Spinal and Biologics
INDUSTRY